Bioline Rx Ltd ADR (NASDAQ: BLRX) is -81.44% lower on its value in year-to-date trading and has touched a low of $0.25 and a high of $1.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BLRX stock was last observed hovering at around $0.30 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.29, the stock is -27.59% and -35.94% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.4 million and changing -1.89% at the moment leaves the stock -58.54% off its SMA200. BLRX registered -79.90% loss for a year compared to 6-month loss of -60.30%. The firm has a 50-day simple moving average (SMA 50) of $0.4628 and a 200-day simple moving average (SMA200) of $0.70725.
The stock witnessed a -28.96% gain in the last 1 month and extending the period to 3 months gives it a -53.97%, and is 4.78% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.95% over the week and 10.61% over the month.
Bioline Rx Ltd ADR (BLRX) has around 38 employees, a market worth around $24.80M and $21.99M in sales. Profit margin for the company is -90.57%. Distance from 52-week low is 16.56% and -84.58% from its 52-week high. The company has generated returns on investments over the last 12 months (-71.70%).
with sales reaching $7.72M over the same period.The EPS is expected to grow by 87.72% this year, but quarterly earnings will post 425.34% year-over-year. Quarterly sales are estimated to grow 60.80% in year-over-year returns.
Bioline Rx Ltd ADR (BLRX) Top Institutional Holders
The shares outstanding are 85.11M, and float is at 84.64M with Short Float at 1.30%.
The top institutional shareholder in the company is ALYESKA INVESTMENT GROUP, L.P. with over 1.95 million shares valued at $1.11 million. The investor’s holdings represent 2.6966% of the BLRX Shares outstanding. As of 2024-06-30, the second largest holder is CVI HOLDINGS, LLC with 0.82 million shares valued at $0.46 million to account for 1.126 of the shares outstanding. The other top investors are ENVESTNET ASSET MANAGEMENT INC which holds 0.21 million shares representing 0.2952% and valued at over $0.12 million, while VALUES FIRST ADVISORS, INC. holds 0.2813 of the shares totaling 0.2 million with a market value of $0.12 million.
Bioline Rx Ltd ADR (BLRX) Insider Activity
#####
